TELA | Tela Bio, Inc. |
Surgical & Medical Instruments & Apparatus |
Book value per $ invested | $ -0.08 |
Leverage | 111.83% |
Market Cap | $ 74.2m |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -41.2m |
Margin | -61.15% |
TELA Bio, Inc., a medical technology company, focuses on the design, development and commercialization of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is headquartered in Malvern, Pennsylvania.